Evidence map›Paper›PMID 40466201›Full record

ArticleCritical care explorations2025

Mortality Prediction Performance Under Geographical, Temporal, and COVID-19 Pandemic Dataset Shift: External Validation of the Global Open-Source Severity of Illness Score Model.

Takeshi Tohyama, Liam G McCoy, Euma Ishii, Sahil Sood, Jesse Raffa, Takahiro Kinoshita, Leo Anthony Celi, Satoru Hashimoto

Abstract readValidation Study
In one paragraph

Article in Critical care explorations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takeshi TohyamaInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA.ORCID 0000-0002-7300-8180
Liam G McCoyInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA.
Euma IshiiBiomedical Informatics and Data Science (BIDS), Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Sahil SoodHarvard University, Cambridge, MA.
Jesse RaffaInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA.
Takahiro KinoshitaMeDiCU, Osaka, Japan.
Leo Anthony CeliInstitute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA.
Satoru HashimotoICU Collaboration Network (ICON), Tokyo, Japan.

Funding

Cardiovascular Innovative Conference grant
6 · The paper itself

Abstract

backgroundRisk-prediction models are widely used for quality of care evaluations, resource management, and patient stratification in research. While established models have long been used for risk prediction, healthcare has evolved significantly, and the optimal model must be selected for evaluation in line with contemporary healthcare settings and regional considerations.

objectivesTo evaluate the geographic and temporal generalizability of the models for mortality prediction in ICUs through external validation in Japan. DERIVATION COHORT: Not applicable. VALIDATION COHORT: The care Japanese Intensive care PAtient Database from 2015 to 2022. PREDICTION MODEL: The Global Open-Source Severity of Illness Score (GOSSIS-1), a modern risk model utilizing machine learning approaches, was compared with conventional models-the Acute Physiology and Chronic Health Evaluation (APACHE-II and APACHE-III)-and a locally calibrated model, the Japan Risk of Death (JROD).

resultsDespite the demographic and clinical differences of the validation cohort, GOSSIS-1 maintained strong discrimination, achieving an area under the curve of 0.908, comparable to APACHE-III (0.908) and JROD (0.910). It also exhibited superior calibration, achieving a standardized mortality ratio (SMR) of 0.89 (95% CI, 0.88-0.90), significantly outperforming APACHE-II (SMR, 0.39; 95% CI, 0.39-0.40) and APACHE-III (SMR, 0.46; 95% CI, 0.46-0.47), and demonstrating a performance close to that of JROD (SMR, 0.97; 95% CI, 0.96-0.99). However, performance varied significantly across disease categories, with suboptimal calibration for neurologic conditions and trauma. While the model showed temporal stability from 2015 to 2019, performance deteriorated during the COVID-19 pandemic, broadly reducing performance across disease categories in 2020. This trend was particularly pronounced in GOSSIS compared with APACHE-III.

conclusionsGOSSIS-1 demonstrates robust discrimination despite substantial geographic dataset shift but shows important calibration variations across disease categories. In particular, in a complex model like GOSSIS-1, stresses on the health system, such as a pandemic, can manifest changes in model calibration.

Indexed as

COVID-19Hospital MortalitySeverity of Illness IndexAgedAPACHEDatabases, FactualFemaleHumansIntensive Care UnitsJapanMachine LearningMaleMiddle AgedPandemicsRisk AssessmentSARS-CoV-2COVID-19dataset shiftexternal validationGlobal Open-Source Severity of Illness Score-1model calibrationrisk-prediction model

Identifiers

PMID40466201
PMCPMC12140679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.